When is Sterile Fill Finish Required?

 

It goes without saying that sterile fill finish is an absolute requirement and we don’t joke with this at Abbvie contract manufacturing. There are four major ways drugs are delivered to the body. They are parenteral, ocular, inhaled, and otic. These four ways bypass a significant number of the body's natural immune systems, which in turn raises the probability of either infection.

Since the FDA wants to ensure that patients are safe, it has mandated that prescriptions administered through these methods must be presented as sterile products.

This categorization encompasses a wide variety of complex medical preparations, including ophthalmic solutions, sterile injectables, reconstituted lyophilized powders for injection, and aqueous-based aerosols for inhalation which we handle at Abbvie contract manufacturing.

As these intricate APIs and formulations become more common, there is a growing demand for aseptic operations, the majority of which are being addressed by contract manufacturers.

Types of Sterilization Processes

One of these two processes can be utilized in the production of sterile pharmaceutical products:

1. Terminal Sterilization

This process comprises packing and sealing products in high-quality surroundings before using a sterilization treatment such as heating or irradiation. This will ensure that they are safe to use.

2. Aseptic Manufacturing and Sterile Fill-Finish

This technique involves first sterilizing the medicinal product, container, and closure separately, as necessary, and then combining them after they have been sterilized (aseptic manufacturing).

Because the product cannot be sterilized in the container it is placed in, containers must be filled and sealed in an environment that is subject to stringent regulations (sterile aseptic fill finish). This presents the pharmaceutical business with one of the most difficult problems it must overcome.

Since aseptic processing is associated with a higher risk due to the increased number of variables involved, multiple FDA guidance have made it abundantly clear that aseptic manufacturing and drug fill finish should only be utilized in circumstances in which terminal sterilization is not feasible.

As a result of performance loss or degradation when exposed to heat or radiation, an increasing number of drug goods and containers cannot be terminally sterilized. This is because formulations are becoming more intricate.

What are the Challenges Associated with Aseptic Processing?

The aseptic fill finish processing method is one of the most challenging methods because it requires careful planning, personnel who have received extensive training and possess the appropriate mindset, and facilities, equipment, and procedures unique to the method.

Maintaining sterility is challenging, and if it is not carried out appropriately, it might jeopardize a patient's life. The ultimate goal of an aseptic manufacturing process is to entirely erase any potential for contamination, regardless of whether the potential for contamination originates from bacteria or microscopic particles that, if given, could put a patient at risk.

At Abbvie contract manufacturing, we understand the need to always adhere to strict FDA standards. This understanding is one of the reasons we are certified, and FDA registered, so our clients can rest assured that they are working with a company that adheres to their needs and requirements.

Reach out to us for fill finish manufacturing and all kinds of pharmaceutical fill finish. We are just a phone call away.